share

1-tert-Butyl 4-Ethyl 3-Oxoazepane-1,4-Dicarboxylate(Wx618505) CAS NO 98977-38-9


Unit Price:

CAS No.:98977-38-9

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

1-tert-Butyl 4-Ethyl 3-Oxoazepane-1,4-Dicarboxylate (Wx618505) is a high-purity, advanced pharmaceutical intermediate characterized by its specific azepane-dicarboxylate structure. This compound is critical for the synthesis of complex active pharmaceutical ingredients (APIs) and novel chemical entities, offering a key building block for medicinal chemistry research and development. It is primarily utilized by pharmaceutical manufacturers, contract research organizations (CROs), and fine chemical synthesis specialists focused on developing new therapeutic agents.

Application

  • Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of complex drug candidates, particularly those targeting neurological and metabolic disorders.
  • Medicinal Chemistry Research: Serves as a versatile scaffold for the design and optimization of new chemical entities in drug discovery programs.
  • API Synthesis: Used in the production of Active Pharmaceutical Ingredients (APIs) requiring the 3-oxoazepane core structure.
  • Fine Chemical Manufacturing: Employed in custom synthesis and contract manufacturing of high-value, specialty organic compounds.
  • Bioconjugation & Probe Development: Potential use in creating biochemical probes or conjugates due to its reactive ester groups.

Basic Information

Product Name 1-tert-Butyl 4-Ethyl 3-Oxoazepane-1,4-Dicarboxylate (Wx618505)
CAS No. 98977-38-9
Molecular Formula C14H23NO5
Molecular Weight 285.34 g/mol
Synonyms 1-(tert-Butoxycarbonyl)-4-ethoxycarbonyl-3-oxoazepane; 3-Oxoazepane-1,4-dicarboxylic acid 1-tert-butyl 4-ethyl ester; 1-Boc-4-ethyl 3-oxoazepane-1,4-dicarboxylate; tert-Butyl 4-ethyl 3-oxoazepane-1,4-dicarboxylate; Ethyl 1-(tert-butoxycarbonyl)-3-oxoazepane-4-carboxylate; WX-618505; Wx618505
EINECS Contact for details

Quality Control

Our 1-tert-Butyl 4-Ethyl 3-Oxoazepane-1,4-Dicarboxylate is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all specifications and test results. Our quality commitment aligns with cGMP principles for pharmaceutical intermediates, ensuring reliability for your critical R&D and production processes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep the container tightly sealed to protect from moisture. Store away from incompatible materials.

Specification

Item Specification
Appearance White to off-white solid
Identification (IR) Conforms to structure
Identification (NMR) Conforms to structure
Purity (HPLC) ≥ 98.0%
Water Content (KF) ≤ 0.5%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.